Temasek Subscribes to Roughly 3.6% of Bayer AG
Posted on 04/17/2018
Singapore’s Temasek Holdings, a sovereign wealth fund that is involved in prolific healthcare deals, agreed to subscribe to 31 million new shares of Bayer AG, corresponding to around 3.6% of the capital stock, for total gross proceeds of €3 billion. With the consent of the Supervisory Board, the Board of Management of Bayer AG resolved […]
